BIOMAT Database Logo BIOMAT Database Logo

Neuromuscular complications in patients given Pavulon (pancuronium bromide) during artificial ventilation. 1985

A A Op de Coul, and P C Lambregts, and J Koeman, and M J van Puyenbroek, and H J Ter Laak, and A A Gabreëls-Festen

This paper reports on 12 patients in a 3-year period (from 1st July 1980 to 1st July 1983) who were treated with artificial ventilation and with the muscle relaxant pancuronium bromide (Pavulon), over a period of 6 days or longer. After discontinuation of this drug these patients developed severe tetraparesis with areflexia, sometimes combined with disturbances of the extraocular and facial muscles and diffuse muscular atrophy, without sensory disturbances. Seven patients recovered completely after 2-5 months, two made an incomplete recovery and three died due to the primary disease. It is suggested that these neuromuscular complications were caused by prolonged high-dosage Pavulon treatment in combination with renal and hepatic disturbances and/or the use of aminoglucosides.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D009133 Muscular Atrophy Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation. Atrophy, Muscle,Neurogenic Muscular Atrophy,Neurotrophic Muscular Atrophy,Atrophies, Muscle,Atrophies, Muscular,Atrophies, Neurogenic Muscular,Atrophies, Neurotrophic Muscular,Atrophy, Muscular,Atrophy, Neurogenic Muscular,Atrophy, Neurotrophic Muscular,Muscle Atrophies,Muscle Atrophy,Muscular Atrophies,Muscular Atrophies, Neurogenic,Muscular Atrophies, Neurotrophic,Muscular Atrophy, Neurogenic,Muscular Atrophy, Neurotrophic,Neurogenic Muscular Atrophies,Neurotrophic Muscular Atrophies
D009413 Nerve Fibers, Myelinated A class of nerve fibers as defined by their structure, specifically the nerve sheath arrangement. The AXONS of the myelinated nerve fibers are completely encased in a MYELIN SHEATH. They are fibers of relatively large and varied diameters. Their NEURAL CONDUCTION rates are faster than those of the unmyelinated nerve fibers (NERVE FIBERS, UNMYELINATED). Myelinated nerve fibers are present in somatic and autonomic nerves. A Fibers,B Fibers,Fiber, Myelinated Nerve,Fibers, Myelinated Nerve,Myelinated Nerve Fiber,Myelinated Nerve Fibers,Nerve Fiber, Myelinated
D009468 Neuromuscular Diseases A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA. Amyotonia Congenita,Oppenheim Disease,Cramp-Fasciculation Syndrome,Fasciculation-Cramp Syndrome, Benign,Foley-Denny-Brown Syndrome,Oppenheim's Disease,Benign Fasciculation-Cramp Syndrome,Benign Fasciculation-Cramp Syndromes,Cramp Fasciculation Syndrome,Cramp-Fasciculation Syndromes,Fasciculation Cramp Syndrome, Benign,Fasciculation-Cramp Syndromes, Benign,Foley Denny Brown Syndrome,Neuromuscular Disease,Oppenheims Disease,Syndrome, Cramp-Fasciculation,Syndrome, Foley-Denny-Brown,Syndromes, Cramp-Fasciculation
D010197 Pancuronium A bis-quaternary steroid that is a competitive nicotinic antagonist. As a neuromuscular blocking agent it is more potent than CURARE but has less effect on the circulatory system and on histamine release. Pancuronium Bromide,Pancuronium Curamed,Pancuronium Organon,Pavulon,Bromide, Pancuronium
D012121 Respiration, Artificial Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2). Ventilation, Mechanical,Mechanical Ventilation,Artificial Respiration,Artificial Respirations,Mechanical Ventilations,Respirations, Artificial,Ventilations, Mechanical
D004576 Electromyography Recording of the changes in electric potential of muscle by means of surface or needle electrodes. Electromyogram,Surface Electromyography,Electromyograms,Electromyographies,Electromyographies, Surface,Electromyography, Surface,Surface Electromyographies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A A Op de Coul, and P C Lambregts, and J Koeman, and M J van Puyenbroek, and H J Ter Laak, and A A Gabreëls-Festen
Pancuronium bromide (Pavulon).
August 1974, AANA journal,
A A Op de Coul, and P C Lambregts, and J Koeman, and M J van Puyenbroek, and H J Ter Laak, and A A Gabreëls-Festen
[Pancuronium bromide--Pavulon].
June 1972, Ugeskrift for laeger,
A A Op de Coul, and P C Lambregts, and J Koeman, and M J van Puyenbroek, and H J Ter Laak, and A A Gabreëls-Festen
Pavulon (pancuronium bromide).
January 1982, Critical care nurse,
A A Op de Coul, and P C Lambregts, and J Koeman, and M J van Puyenbroek, and H J Ter Laak, and A A Gabreëls-Festen
[Pancuronium bromide (Pavulon) in urologic surgery].
July 1971, Zeitschrift fur praktische Anasthesie und Wiederbelebung,
A A Op de Coul, and P C Lambregts, and J Koeman, and M J van Puyenbroek, and H J Ter Laak, and A A Gabreëls-Festen
Proceedings: Pancuronium bromide (Pavulon, Organon). A new non-depolarizing neuromuscular blocker.
June 1975, West African journal of pharmacology and drug research,
A A Op de Coul, and P C Lambregts, and J Koeman, and M J van Puyenbroek, and H J Ter Laak, and A A Gabreëls-Festen
[Clinical use of pancuronium bromide (Pavulon)].
January 1971, Revista brasileira de anestesiologia,
A A Op de Coul, and P C Lambregts, and J Koeman, and M J van Puyenbroek, and H J Ter Laak, and A A Gabreëls-Festen
[Clinical study of pancuronium bromide (Pavulon)].
September 1972, Bordeaux medical,
A A Op de Coul, and P C Lambregts, and J Koeman, and M J van Puyenbroek, and H J Ter Laak, and A A Gabreëls-Festen
The anticholinesterase activity of pancuronium bromide (Pavulon).
January 1974, Biochemical pharmacology,
A A Op de Coul, and P C Lambregts, and J Koeman, and M J van Puyenbroek, and H J Ter Laak, and A A Gabreëls-Festen
Some clinical experiences with a new neuromuscular blocking drug--pancuronium bromide (Pavulon NA97).
December 1968, Irish journal of medical science,
A A Op de Coul, and P C Lambregts, and J Koeman, and M J van Puyenbroek, and H J Ter Laak, and A A Gabreëls-Festen
Pancuronium bromide (Pavulon) evaluation of its clinical pharmacology.
September 1971, Canadian Anaesthetists' Society journal,
Copied contents to your clipboard!